CD8a Antibody FITC 11-0088-42 from Thermo Fisher Scientific

Product Specs
ItemCD8a Antibody FITC
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number11-0088-42
Quantity100 Tests
ApplicationsFlow Cytometry
Concentration5 µL/Test
Conjugate/TagFITC
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD8a
IsotypeIgG1 kappa
CloneRPA-T8
HostMouse
NCBI Full Gene NameCD8 subunit beta, CD8 subunit alpha
NCBI Gene AliasesLY3, CD8alpha, CD8beta, Leu2, CD8B1, p32, LEU2, Ly-3, CD8, P37, LYT3
ClonalityMonoclonal
PurityAffinity chromatography
Storage Temperature4° C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
Storage4°C, store in dark, DO NOT FREEZE!

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Colostrum extracellular vesicles are neuroprotective in models of Parkinson's diseaseTheranosticsJanuary 22, 2026Dawson Hollingsworth, Shefali Srivastava, Samia Akter, Mohit Kumar, Soumya Sagar Dey, Sudipta Panja, Xiaoqing Du, Arnab Saha, Pravin Yeapuri, Shaurav Bhattarai, et al.eBioscience, CA, USA), PE-Cy7-anti-CD4 (cat. No. 25-0042-82; eBioscience, CA, USA), FITC-anti-CD8 (Cat. No. 11-0088-42, eBioscience, CA, USA) and PE-anti-CD25 (Cat. number. 12-0251-82; eBioscience, CA, USA). FoxP3 cells

(2) YAP as a therapeutic target to reverse trastuzumab resistanceGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationSeptember 1, 2025Nam AR, Oh KS, Bang JH, Jeong Y, Choo SY, Kim HJ, Lee SI, Kim JM, Yoon J, Kim TY, et al.CD4 monoclonal antibody (RPA-T4), PE (Invitrogen, #12–0049-42), CD8a monoclonal antibody (RPA-T8), FITC (Invitrogen, #11-0088-42), CD279 (PD-1) monoclonal antibody (MIH4), PE (Invitrogen, #11-9969-42), Pacific Blue™ anti-human/mouse granzyme B recombinant

(3) Protocol for isolation of tumor-derived extracellular vesicles and functional studies on human T cell subsetsSTAR protocolsJune 21, 2024Swatler J, Targońska A, Turos-Korgul L, Mosieniak G, Piwocka K.

(4) Enhanced and sustained T cell activation in response to fluid shear stressiScienceJune 21, 2024Sarna NS, Desai SH, Kaufman BG, Curry NM, Hanna AM, King MR."For flow cytometry: CD8a Monoclonal Antibody (Host: Mouse, clone: RPA-T8) - FITC",Thermo Fisher Scientific,Cat#:11-0088-42; RRID:AB_10669559 For flow cytometry: Human TruStain FcX,BioLegend,Cat#:422301; RRID:AB_2818986 For flow cytometry

(5) Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesNature communicationsApril 26, 2024Kaiser JA, Nelson CE, Liu X, Park HS, Matsuoka Y, Luongo C, Santos C, Ahlers LRH, Herbert R, Moore IN, et al.

(6) Immune response induced by standard and fractional doses of 17DD yellow fever vaccineNPJ vaccinesMarch 8, 2024Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, et al.

(7) TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathwaysThe Journal of experimental medicineDecember 4, 2023Chan W, Cao YM, Zhao X, Schrom EC, Jia D, Song J, Sibener LV, Dong S, Fernandes RA, Bradfield CJ, et al.

(8) Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell ImmunityInternational journal of molecular sciencesOctober 30, 2023Van Den Eeckhout B, Ballegeer M, De Clercq J, Burg E, Saelens X, Vandekerckhove L, Gerlo S.

(9) Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1Cancer medicineAugust 1, 2023Li D, Zhou X, Xu W, Chen Y, Mu C, Zhao X, Yang T, Wang G, Wei L, Ma B.

(10) Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastomaOncology lettersJuly 1, 2023Zhang Y, Luo F, Dong K.

(11) Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinomaCancer immunology, immunotherapy : CIIJune 1, 2023Lu T, Zhang J, Lu S, Yang F, Gan L, Wu X, Song H, Liu S, Xu C, Han D, et al.

(12) PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cellsNature communicationsDecember 12, 2022Li Q, Zhang L, You W, Xu J, Dai J, Hua D, Zhang R, Yao F, Zhou S, Huang W, et al.

(13) VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasiseLifeDecember 9, 2022Li J, Huang D, Lei B, Huang J, Yang L, Nie M, Su S, Zhao Q, Wang Y.

(14) Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cellsCancer scienceJune 1, 2022Huang M, Huang X, Huang N.following: APC‐CD4 (BD biosciences, 561840), PE‐FOXP3 (eBioscience, 12‐4776‐41), and FITC‐CD8a (eBioscience, 11‐0088‐42). Cells were washed with washing solution and stained with surface antibody and fixable viability dye

(15) Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid modelsFrontiers in oncologyJanuary 1, 2022Tan D, An J, Gong M, Wang H, Li H, Meng H, Zhang C, Zhao Y, Ge X, Shi C.

(16) Multipeptide stimulated PBMCs generate T(EM)/T(CM) for adoptive cell therapy in multiple myelomaOncotargetSeptember 28, 2021Vardam-Kaur T, Pathangey LB, McCormick DJ, Bergsagel PL, Cohen PA, Gendler SJ.

(17) Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomesNature communicationsMay 21, 2021Renner K, Schwittay T, Chaabane S, Gottschling J, Müller C, Tiefenböck C, Salewski JN, Winter F, Buchtler S, Balam S, et al.

(18) Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's diseaseNPJ Parkinson's diseaseMay 13, 2021Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH.

(19) Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivoTheranosticsJanuary 1, 2021Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, Zhang Z, Wu T, Peng H, Huang Y, et al.

(20) Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF InhibitionFrontiers in immunologyJanuary 1, 2021Yeku OO, Rao TD, Laster I, Kononenko A, Purdon TJ, Wang P, Cui Z, Liu H, Brentjens RJ, Spriggs D.

Be the First to Write a Review!

Flow

Flow

Flow

CD8a Antibody FITC from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (54)

Reviews

CD8a Antibody FITC from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map